Polymyalgia rheumatica is an inflammatory disease producing pain and stiffness, mainly in
the shoulders and pelvic girdle, in people older than 50 years. Elevation of acute phase …

Polymyalgia rheumatica (PMR) and giant cell arteritis (GCA) are inflammatory diseases that
typically affect white individuals> 50 years. Women are affected∼ 2–3 times more often than …

Importance Few treatments are available for patients with glucocorticoid-dependent
polymyalgia rheumatica. IL-6 antagonists may reduce disease activity in patients with active …

Background Polymyalgia rheumatica (PMR) is a common inflammatory disease in elderly
persons whose mechanism of pathogenesis has not been elucidated. Glucocorticoids are …

Giant cell arteritis (GCA) is the most common type of primary vasculitis in Western countries.
Polymyalgia rheumatica (PMR) is the second most common inflammatory rheumatic disease …

Background Glucocorticoids are the cornerstone treatment of polymyalgia rheumatica (PMR)
but induce adverse events. Objectives To evaluate the efficacy and safety of first-line …

Objectives To better define the spectrum of new-onset post-COVID-19 and post-COVID-19
vaccine inflammatory rheumatic diseases (IRD) from a large multicentric observational …

Objective Interleukin‐6 (IL‐6) is a pivotal cytokine in the pathogenesis of polymyalgia
rheumatica (PMR), yet the efficacy of IL‐6 blockade with tocilizumab (TCZ) for the treatment …

Polymyalgia rheumatica is an inflammatory rheumatic disease of the elderly characterised
by pain and stiffness in the neck and pelvic girdle, and is the second most common …

Objectives To determine whether whole-body MRI defines clinically relevant subgroups
within polymyalgia rheumatica (PMR) including glucocorticoid responsiveness. Methods 22 …